Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for Cisplatin-induced Nephrotoxicity and Ototoxicity
NCT04817904Phase 2Unknown
- Sponsor
- Cairo University
- Start
- Nov 2020
- Primary completion
- Aug 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rosuvastatin in cisplatin-induced nephrotoxicity (CIN), cisplatin-induced ototoxicity, sponsored by Cairo University. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
cisplatin-induced nephrotoxicity (CIN)cisplatin-induced ototoxicity
Beyond the preview
Go deeper on NCT04817904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04817904.